You have free access to this content

Hepatology

Cover image for Vol. 53 Issue 4

April 2011

Volume 53, Issue 4

Pages 1073–1416

  1. Comments from the Editors

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Special Article
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    1. You have free access to this content
      Alcohol and lipid traffic don't mix (pages 1073–1075)

      Mark A. McNiven and Carol A. Casey

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24277

  2. Editorials

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Special Article
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    1. You have free access to this content
  3. Viral Hepatitis

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Special Article
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    1. You have free access to this content
      Host apolipoprotein b messenger RNA-editing enzyme catalytic polypeptide-like 3G is an innate defensive factor and drug target against hepatitis C virus (pages 1080–1089)

      Zong-Gen Peng, Zhi-Yun Zhao, Yan-Ping Li, Yu-Ping Wang, Lan-Hu Hao, Bo Fan, Yu-Huan Li, Yue-Ming Wang, Yong-Qiang Shan, Yan-Xing Han, Yan-Ping Zhu, Jian-Rui Li, Xue-Fu You, Zhuo-Rong Li and Jian-Dong Jiang

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24160

    2. You have free access to this content
    3. You have free access to this content
      Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon (pages 1100–1108)

      Adrian M. Di Bisceglie, Anne M. Stoddard, Jules L. Dienstag, Mitchell L. Shiffman, Leonard B. Seeff, Herbert L. Bonkovsky, Chihiro Morishima, Elizabeth C. Wright, Kristin K. Snow, William M. Lee, Robert J. Fontana, Timothy R. Morgan, Marc G. Ghany and for the HALT-C Trial Group

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24169

    4. You have free access to this content
      Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1 (pages 1109–1117)

      William Sievert, Gregory J. Dore, Geoffrey W. McCaughan, Motoko Yoshihara, Darrell H. Crawford, Wendy Cheng, Martin Weltman, William Rawlinson, Bishoy Rizkalla, Jean K. DePamphilis, Stuart K. Roberts and on behalf of the CHARIOT Study Group

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24180

    5. You have free access to this content
      Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C (pages 1118–1126)

      Davide Bitetto, Giovanna Fattovich, Carlo Fabris, Elisa Ceriani, Edmondo Falleti, Ezio Fornasiere, Michela Pasino, Donatella Ieluzzi, Annarosa Cussigh, Sara Cmet, Mario Pirisi and Pierluigi Toniutto

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24201

    6. You have free access to this content
      C-Src is required for complex formation between the hepatitis C virus–encoded proteins NS5A and NS5B: A prerequisite for replication (pages 1127–1136)

      Andreas Pfannkuche, Katrin Büther, Juliane Karthe, Marion Poenisch, Ralf Bartenschlager, Mirko Trilling, Hartmut Hengel, Dieter Willbold, Dieter Häussinger and Johannes Georg Bode

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24214

    7. You have free access to this content
    8. You have free access to this content
      Randomized trial of lamivudine versus entecavir in entecavir-treated patients with undetectable hepatitis B virus DNA: Outcome at 2 Years (pages 1148–1153)

      James Fung, Ching-Lung Lai, John Yuen, Charles Cheng, Ringo Wu, Danny Ka-Ho Wong, Wai-Kay Seto, Ivan Fan-Ngai Hung and Man-Fung Yuen

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24192

    9. You have free access to this content
      Interferon-β and interferon-λ signaling is not affected by interferon-induced refractoriness to interferon-α in vivo (pages 1171–1180)

      Zuzanna Makowska, Francois H. T. Duong, Gaia Trincucci, David F. Tough and Markus H. Heim

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24189

  4. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Special Article
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    1. You have free access to this content
      Transcription coactivator mediator subunit MED1 Is required for the development of fatty liver in the mouse (pages 1164–1174)

      Liang Bai, Yuzhi Jia, Navin Viswakarma, Jiansheng Huang, Aurore Vluggens, Nathan E. Wolins, Nadereh Jafari, M. Sambasiva Rao, Jayme Borensztajn, Gongshe Yang and Janardan K. Reddy

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24155

    2. You have free access to this content
      Regulation of hepatic fat and glucose oxidation in rats with lipid-induced hepatic insulin resistance (pages 1175–1181)

      Tiago C. Alves, Douglas E. Befroy, Richard G. Kibbey, Mario Kahn, Roberto Codella, Rui A. Carvalho, Kitt Falk Petersen and Gerald I. Shulman

      Version of Record online: 11 MAR 2011 | DOI: 10.1002/hep.24170

  5. Hepatobiliary Malignancies

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Special Article
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    1. You have free access to this content
      Hepatocellular adenomas: Accuracy of magnetic resonance imaging and liver biopsy in subtype classification (pages 1182–1191)

      Maxime Ronot, Stephane Bahrami, Julien Calderaro, Dominique-Charles Valla, Pierre Bedossa, Jacques Belghti, Valérie Vilgrain and Valérie Paradis

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24147

    2. You have free access to this content
      Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells (pages 1192–1205)

      Jörg Schrader, Timothy T. Gordon-Walker, Rebecca L. Aucott, Mariëlle van Deemter, Alexander Quaas, Shaun Walsh, Daniel Benten, Stuart J. Forbes, Rebecca G. Wells and John P. Iredale

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24108

    3. You have free access to this content
      Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma (pages 1206–1216)

      Eishiro Mizukoshi, Yasunari Nakamoto, Kuniaki Arai, Tatsuya Yamashita, Akito Sakai, Yoshio Sakai, Takashi Kagaya, Taro Yamashita, Masao Honda and Shuichi Kaneko

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24149

    4. You have free access to this content
      Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: A cohort study of parous women in Taiwan (pages 1217–1225)

      Chyng-Wen Fwu, Yin-Chu Chien, San-Lin You, Kenrad E. Nelson, Gregory D. Kirk, Hsu-Sung Kuo, Manning Feinleib and Chien-Jen Chen

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24150

    5. You have free access to this content
      Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53 (pages 1226–1236)

      Diego F. Calvisi, Maria M. Simile, Sara Ladu, Maddalena Frau, Matthias Evert, Maria L. Tomasi, Maria I. Demartis, Lucia Daino, Maria A. Seddaiu, Stefania Brozzetti, Francesco Feo and Rosa M. Pascale

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24174

    6. You have free access to this content
      Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma (pages 1237–1245)

      Waka Ohishi, Saeko Fujiwara, John B. Cologne, Gen Suzuki, Masazumi Akahoshi, Nobuo Nishi, Masataka Tsuge and Kazuaki Chayama

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24207

  6. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Special Article
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    1. You have free access to this content
      Hedgehog activity, epithelial-mesenchymal transitions, and biliary dysmorphogenesis in biliary atresia (pages 1246–1258)

      Alessia Omenetti, Lee M. Bass, Robert A. Anders, Maria G. Clemente, Heather Francis, Cynthia D. Guy, Shannon McCall, Steve S. Choi, Gianfranco Alpini, Kathleen B. Schwarz, Anna Mae Diehl and Peter F. Whitington

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24156

    2. You have free access to this content
      Transcription factor Fra-1 induces cholangitis and liver fibrosis (pages 1287–1297)

      Trayana Kireva, Annette Erhardt, Gisa Tiegs, Herbert Tilg, Helmut Denk, Johannes Haybaeck, Elmar Aigner, Alexander Moschen, Jörg H. Distler, Georg Schett and Jochen Zwerina

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24175

    3. You have free access to this content
      Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis (pages 1270–1281)

      Shinji Shimoda, Kenichi Harada, Hiroaki Niiro, Ken Shirabe, Akinobu Taketomi, Yoshihiko Maehara, Koichi Tsuneyama, Yasuni Nakanuma, Patrick Leung, Aftab A. Ansari, M. Eric Gershwin and Koichi Akashi

      Version of Record online: 11 MAR 2011 | DOI: 10.1002/hep.24194

    4. You have free access to this content
      Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice (pages 1282–1293)

      Tsutomu Matsubara, Naoki Tanaka, Andrew D. Patterson, Joo-Youn Cho, Kristopher W. Krausz and Frank J. Gonzalez

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24193

  7. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Special Article
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    1. You have free access to this content
      Occludin is regulated by epidermal growth factor receptor activation in brain endothelial cells and brains of mice with acute liver failure (pages 1294–1305)

      Feng Chen, Tomohide Hori, Norifumi Ohashi, Ann-Marie Baine, Christopher B. Eckman and Justin H. Nguyen

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24161

    2. You have free access to this content
      Reticulon 4B (Nogo-B) is a novel regulator of hepatic fibrosis (pages 1306–1315)

      Dahai Zhang, Teruo Utsumi, Hui-Chun Huang, Lili Gao, Panjamaporn Sangwung, Chuhan Chung, Kazunori Shibao, Kohji Okamoto, Koji Yamaguchi, Roberto J. Groszmann, Levente Jozsef, Zhengrong Hao, William C. Sessa and Yasuko Iwakiri

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24200

  8. Liver Injury/Regeneration

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Special Article
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    1. You have free access to this content
      In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis (pages 1316–1322)

      A.J. di Mambro, R. Parker, A. McCune, F. Gordon, C.M. Dayan and P. Collins

      Version of Record online: 11 MAR 2011 | DOI: 10.1002/hep.24159

    2. You have free access to this content
      Fibrinogen-γ proteolysis and solubility dynamics during apoptotic mouse liver injury: Heparin prevents and treats liver damage (pages 1323–1332)

      Sujith V. W. Weerasinghe, David S. Moons, Peter J. Altshuler, Yatrik M. Shah and M. Bishr Omary

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24203

  9. Liver Biology/Pathobiology

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Special Article
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    1. You have free access to this content
      Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice (pages 1333–1341)

      Emilio Ramos, Léon Kautz, Richard Rodriguez, Michael Hansen, Victoria Gabayan, Yelena Ginzburg, Marie-Paule Roth, Elizabeta Nemeth and Tomas Ganz

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24178

    2. You have free access to this content
      Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice (pages 1342–1351)

      Won-Il Jeong, Ogyi Park, Yang-Gun Suh, Jin-Seok Byun, So-Young Park, Earl Choi, Ja-Kyung Kim, Hyojin Ko, Hua Wang, Andrew M. Miller and Bin Gao

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24190

    3. You have free access to this content
      Notch1 differentially regulates oncogenesis by wildtype p53 overexpression and p53 mutation in grade III hepatocellular carcinoma (pages 1352–1362)

      Seung-Oe Lim, Young Min Park, Hyeon Seop Kim, Xiaoyuan Quan, Jeong Eun Yoo, Young Nyun Park, Gi Hong Choi and Guhung Jung

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24208

  10. Special Article

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Special Article
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    1. You have free access to this content
      New staging system and a registry for perihilar cholangiocarcinoma (pages 1363–1371)

      Michelle L. DeOliveira, Richard D. Schulick, Yuji Nimura, Charles Rosen, Gregory Gores, Peter Neuhaus and Pierre-Alain Clavien

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24227

  11. Reviews

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Special Article
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    1. You have free access to this content
    2. You have free access to this content
      Drug-induced cholestasis (pages 1377–1387)

      Manmeet S. Padda, Mayra Sanchez, Abbasi J. Akhtar and James L. Boyer

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24229

  12. Hepatology Elsewhere

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Special Article
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    1. You have free access to this content
      CD13: Waving the flag for a novel cancer stem cell target (pages 1388–1390)

      Bruno Christ, Peggy Stock and Matthias M. Dollinger

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24222

    2. You have free access to this content
    3. You have free access to this content
  13. Image of the Month

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Special Article
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    1. You have free access to this content
      Liver mass with central calcification (pages 1397–1398)

      Andreas Lanitis and Christian Toso

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24086

  14. Correspondence

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Special Article
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    1. You have free access to this content
      Insurance status and treatment candidacy of patients with hepatitis C: Taiwanese patients are luckier (page 1399)

      Chia-Yen Dai, Ming-Lun Yeh, Jee-Fu Huang, Wan-Long Chuang and Ming-Lung Yu

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24197

    2. You have free access to this content
      Reply: (page 1400)

      Maria Stepanova and Zobair M. Younossi

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24210

    3. You have free access to this content
      Ribavirin enhances interferon-stimulated gene transcription by activation of the interferon-stimulated response element (pages 1400–1401)

      Qiuwei Pan, Hugo W. Tilanus, Harry L.A. Janssen and Luc J. W. van der Laan

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24202

    4. You have free access to this content
      Reply: (page 1402)

      Emmanuel Thomas and T. Jake Liang

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24226

    5. You have free access to this content
    6. You have free access to this content
      Correspondence (page 1403)

      Mindie Nguyen and Khoa Lam

      Version of Record online: 11 MAR 2011 | DOI: 10.1002/hep.24225

    7. You have free access to this content
      Insulin sensitizers in nonalcoholic steatohepatitis (pages 1404–1405)

      Stephen A. Harrison, Steven Schenker and Kenneth Cusi

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24179

    8. You have free access to this content
      Reply: (page 1405)

      Vlad Ratziu, Stephen Caldwell and Brent A. Neuschwander-Tetri

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24233

    9. You have free access to this content
      “Real-Life” comparison of pegylated-interferon 2a versus 2b combination therapy of chronic hepatitis C virus (pages 1453–1454)

      Julian Schulze zur Wiesch, Neele Pudelski, Lena Hoepner, Michael Supplieth, Peter Buggisch, Ansgar W. Lohse and Stefan Lüth

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24185

    10. You have free access to this content
      Reply: (page 1407)

      Tahany Awad, Kristian Thorlund, Goran Hauser, Davor Stimac, Mahasen Mabrouk and Christian Gluud

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24236

    11. You have free access to this content
      Warning: Genome-wide association studies can be misleading. An example in hepatology (page 1408)

      Pierre Galichon, Alexandre Hertig, Eric Rondeau and Laurent Mesnard

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24198

    12. You have free access to this content
      Reply: (pages 1408–1409)

      Robert J. Clifford and Kenneth H. Buetow

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24240

    13. You have free access to this content
    14. You have free access to this content
      Interferon induced protein 10 remains a useful biomarker of treatment failure in patients stratified for the interleukin-28B rs12979860 Haplotype (pages 1410–1411)

      Matthew L. Albert, Armanda Casrouge, Stéphane Chevaliez, Christophe Hézode, Isabelle Rosa, Philippe Renard, Vincent Mallet, Arnaud Fontanet, Jean-Michel Pawlotsky and Stanislas Pol

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24055

    15. You have free access to this content
    16. You have free access to this content
      Beta-blockers have no effect on outcomes in patients with cirrhosis and severe infections (pages 1412–1413)

      Arnaud Galbois, Vincent Das, Dominique Thabut, Eric Maury, Hafid Ait-Oufella, Chantal Housset and Bertrand Guidet

      Version of Record online: 10 JAN 2011 | DOI: 10.1002/hep.24053

    17. You have free access to this content
      Depression and antiviral response to interferon-based therapy for hepatitis C virus infection (pages 1413–1414)

      Jennifer M. Loftis, Benjamin J. Morasco and Peter Hauser

      Version of Record online: 10 JAN 2011 | DOI: 10.1002/hep.24064

  15. Corrections

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Special Article
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    1. You have free access to this content
      Corrections (page 1415)

      Version of Record online: 11 MAR 2011 | DOI: 10.1002/hep.24223

      This article corrects:
    2. You have free access to this content
      Correction (page 1415)

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24261

      This article corrects:
    3. You have free access to this content
    4. You have free access to this content
      Correction (page 1415)

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24258

    5. You have free access to this content
      Correction (page 1416)

      Version of Record online: 7 APR 2011 | DOI: 10.1002/hep.24259

      This article corrects:

SEARCH

SEARCH BY CITATION